Metal Oxide Nanoparticles Induce Unique Inflammatory Footprints in the Lung: Important Implications for Nanoparticle Testing
Open Access
- 1 December 2010
- journal article
- Published by Environmental Health Perspectives in Environmental Health Perspectives
- Vol. 118 (12), 1699-1706
- https://doi.org/10.1289/ehp.1002201
Abstract
Background Metal oxide nanoparticles (NPs) have been widely used in industry, cosmetics, and biomedicine. Objectives We examined hazards of several well-characterized high production volume NPs because of increasing concern about occupational exposure via inhalation. Methods A panel of well-characterized NPs [cerium oxide (CeO2NP), titanium dioxide (TiO2NP), carbon black (CBNP), silicon dioxide (SiO2NP), nickel oxide (NiONP), zinc oxide (ZnONP), copper oxide (CuONP), and amine-modified polystyrene beads] was instilled into lungs of rats. We evaluated the inflammation potencies of these NPs 24 hr and 4 weeks postinstillation. For NPs that caused significant inflammation at 24 hr, we then investigated the characteristics of the inflammation. All exposures were carried out at equal-surface-area doses. Results Only CeO2NP, NiONP, ZnONP, and CuONP were inflammogenic to the lungs of rats at the high doses used. Strikingly, each of these induced a unique inflammatory footprint both acutely (24 hr) and chronically (4 weeks). Acutely, patterns of neutrophil and eosinophil infiltrates differed after CeO2NP, NiONP, ZnONP, and CuONP treatment. Chronic inflammatory responses also differed after 4 weeks, with neutrophilic, neutrophilic/lymphocytic, eosinophilic/fibrotic/granulomatous, and fibrotic/granulomatous inflammation being caused respectively by CeO2NP, NiONP, ZnONP, and CuONP. Conclusion Different types of inflammation imply different hazards in terms of pathology, risks, and risk severity. In vitro testing could not have differentiated these complex hazard outcomes, and this has important implications for the global strategy for NP hazard assessment. Our results demonstrate that NPs cannot be viewed as a single hazard entity and that risk assessment should be performed separately and with caution for different NPs.Keywords
This publication has 34 references indexed in Scilit:
- Current in vitro methods in nanoparticle risk assessment: Limitations and challengesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- Efficacy of Simple Short-Term in Vitro Assays for Predicting the Potential of Metal Oxide Nanoparticles to Cause Pulmonary InflammationEnvironmental Health Perspectives, 2009
- The limits of testing particle-mediated oxidative stress in vitro in predicting diverse pathologies; relevance for testing of nanoparticlesParticle and Fibre Toxicology, 2009
- Lung Toxicity of 16 Fine Particles on Intratracheal Instillation in a Bioassay Model Using F344 Male RatsToxicologic Pathology, 2008
- Concordance BetweenInVitroandInVivoDosimetry in the Proinflammatory Effects of Low-Toxicity, Low-Solubility Particles: The Key Role of the Proximal Alveolar RegionInhalation Toxicology, 2008
- The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface areaOccupational and Environmental Medicine, 2007
- Grey Gooon the Skin? Nanotechnology, Cosmetic and Sunscreen SafetyCritical Reviews in Toxicology, 2007
- Safe handling of nanotechnologyNature, 2006
- Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine ParticlesEnvironmental Health Perspectives, 2005
- Association of Adrenal Pheochromocytoma and Lung Pathology in Inhalation Studies with Particulate Compounds in the Male F344 Rat—The National Toxicology Program ExperienceToxicologic Pathology, 2002